Nath Bio-Genes (India) Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Nath Bio-Genes (India) heeft een totaal eigen vermogen van ₹6.4B en een totale schuld van ₹1.3B, wat de schuld-eigenvermogensverhouding op 19.9% brengt. De totale activa en totale passiva bedragen respectievelijk ₹8.3B en ₹1.9B. De EBIT Nath Bio-Genes (India) is ₹461.8M waardoor de rentedekking 5.5 is. Het heeft contanten en kortetermijnbeleggingen van ₹20.8M.
Belangrijke informatie
19.9%
Verhouding schuld/eigen vermogen
₹1.27b
Schuld
| Rente dekkingsratio | 5.5x |
| Contant | ₹20.77m |
| Aandelen | ₹6.40b |
| Totaal verplichtingen | ₹1.88b |
| Totaal activa | ₹8.28b |
Recente financiële gezondheidsupdates
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹5.2B ) NATHBIOGEN } overtreffen de korte termijn passiva ( ₹1.8B ).
Langlopende schulden: De kortetermijnactiva NATHBIOGEN ( ₹5.2B ) overtreffen de langetermijnschulden ( ₹68.6M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 19.6% ) NATHBIOGEN wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van NATHBIOGEN is de afgelopen 5 jaar gestegen van 12.2% naar 19.9%.
Schuldendekking: De schuld van NATHBIOGEN wordt niet goed gedekt door de operationele kasstroom ( 8.8% ).
Rentedekking: De rentebetalingen op de schuld van NATHBIOGEN worden goed gedekt door EBIT ( 5.5 x dekking).